Abstract
The contribution of the polymorphic markers of cytochrome P450 genes to respiratory diseases caused by smoking and occupational factors has been assessed. For this purpose, PCR-RFLP analysis of the CYP1B1 (rs1056836, 4326C > G), CYP2F1 (rs11399890, c.14_15insC), CYP2J2 (rs890293, -76G > T), and CYP2S1 (rs34971233, 13106C > T and rs338583, 13255A > G) gene polymorphisms has been performed. The analysis has shown that CYP1B1 (rs1056836, 4326C > G) and CYP2F1 (rs11399890, c.14_15insC) polymorphisms may contribute to the development of occupational chronic bronchitis. The proportion of CYP1B1*1*3 heterozygotes in the group of patients with occupational chronic bronchitis is considerably greater than in the group of healthy workers (69.16% versus 53.29%; χ2 = 5.94, p = 0.02, p cur = 0.04, OR = 1.97, the 95% CI is 1.13–3.42). Patients with occupational chronic bronchitis and healthy workers significantly differed from each other in the CYP2F1 genotypes frequency distribution (rs11399890, c.14_15insC) (χ2 = 6.18, d.f. = 2, p = 0.05). CYP2F1 wild type/ins heterozygous genotype frequency is higher in healthy workers (36.08%) than in patients (22.22%) (χ2 = 5.48, p = 0.02, p cur = 0.04, OR = 0.51, the 95% CI is 0.28–0.90). No association has been found between the CYP2J2 (rs890293, −76G > T) or CYP2S1 (rs34971233, 13106C > T, and rs338583, 13255A > G) gene polymorphisms and respiratory diseases.
Similar content being viewed by others
References
GOLD Workshop Report: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2009, www.goldcopd.com.
Chuchalin, A.G., Khronicheskie obstruktivnye bolezni legkikh (Chronic Obstructive Pulmonary Disease), Moscow: BINOM, 1999.
Gichev, Yu.P., Zagryaznenie okruzhayushchei sredy i zdorov’e cheloveka (Pechal’nyi opyt Rossii) (Environmental Pollution and the Human Health (Unhappy Experience of Russia)), Novosibirsk: Sibirskoye Otdelenie Ross. Akad. Med. Nauk, 2002.
Spitsyn, V.A., Ekologicheskaya genetika cheloveka (Ecological Human Genetics), Moscow: Nauka, 2008.
Hukkanen, J., Xenobiotic-Metabolizing Cytochrome P450 Enzymes in Human Lung, http://herkules.oulu.fi/isbn9514258649/.
Ingelman-Sundberg, M., Human Drug Metabolising Cytochrome P450 Enzymes: Properties and Polymorphism, Naunyn Schmiedebergs Arch. Pharmacol., 2004, vol. 369, no. 1, pp.89–104.
Nelson, D.R., The Cytochrome P450 Homepage, Hum. Genomics, 2009, vol. 4, no. 1, pp. 59–65.
Rodriguez-Antona, C., Gomez, A., Karlgren, M., et al., Molecular Genetics and Epigenetics of the Cytochrome P450 Gene Family and Its Relevance for Cancer Risk and Treatment, Hum. Genet., 2010, vol. 127, no. 1, pp. 1–17.
Goodman, M.T., McDuffie, K., Kolonel, L.N., et al., Case-Control Study of Ovarian Cancer and Polymorphisms in Genes Involved in Catecholestrogen Formation and Metabolism, Cancer Epidemiol. Biomarkers Prev., 2001, vol. 10, no. 3, pp. 209–216.
Saarikoski, S.T., Suitiala, T., Holmila, R., et al., Identification of Genetic Polymorphisms of CYP2S1 in a Finnish Caucasian Population, Mutat. Res., 2004, vol. 554, nos. 1–2, pp. 267–277.
Spiecker, M., Darius, H., Hankeln, T., et al., Risk of Coronary Artery Disease Associated with Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2, Circulation, 2004, vol. 110, no. 15, pp. 2132–2136.
Tournel, G., Cauffiez, C., Billaut Laden, I., et al., Molecular Analysis of the CYP2F1 Gene: Identification of a Frequent Non Functional Allelic Variant, Mutat. Res., 2007, vol. 617, nos. 1–2, pp. 79–89.
Tournel, G., Cauffiez, C., Leclerc, J., et al., CYP2F1 Genetic Polymorphism: Identification of Interethnic Variations, Chem. Unserer Zeit, 2007, vol. 37, p. 1433.
Glanz, S.A., BIOSTATISTICA, Primer of Biostatistics Version 4.03, McGraw Hill, 1998.
Korytina, G.F., Akhmadishina, L.Z., and Viktorova, T.V., The Frequencies of Polymorphic Variants of the CYP1F1 and CYP2F1 Genes in Three Ethnic Groups of the Republic of Bashkortostan and in Patients with Chronic Obstructive Pulmonary Disease, Mol. Biol. (Moscow), 2010, vol. 44, no. 1, pp. 33–41.
Polonikov, A.V., Ivanov, V.P., and Solodilova, M.A., Genetic Variation of Genes for Xenobiotic-Metabolizing Enzymes and Risk of Bronchial Asthma: The Importance of Gene-Gene and Gene-Environment Interactions for Disease Susceptibility, J. Hum. Genet., 2009, vol. 54, no. 8, pp. 440–9.
Timofeeva, M.N., Kropp, S., Sauter, W., et al., CYP450 Polymorphisms as Risk Factors for Early-Onset Lung Cancer: Gender-Specific Differences, Carcinogenesis, 2009, vol. 30, no. 7, pp. 1161–1169.
Baldwin, R.M., Jewell, W.T., Fanucchi, M.V., et al., Comparison of Pulmonary/Nasal CYP2F Expression Levels in Rodents and Rhesus Macaque, J. Pharmacol. Exp. Ther., 2004, vol. 309, p. 127.
Polonikov, A.V., Ivanov, V.P., Solodilova, M.A., et al., Promoter Polymorphism G-50T of a Human CYP2J2 Epoxygenase Gene Is Associated with Common Susceptibility to Asthma, Chest, 2007, vol. 132, no. 1, pp. 120–126.
Kumarakulasingham, M., Rooney, P.H., Dundas, S.R., et al., Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis, Clin. Cancer Res., 2005, vol. 11, no. 10, pp. 3758–3765.
Downie, D., McFadyen, M.C., Rooney, P.H., et al., Profiling Cytochrome P450 Expression in Ovarian Cancer: Identification of Prognostic Markers, Clin. Cancer Res., 2005, vol. 11, no. 20, pp. 7369–7375.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.Z. Akhmadishina, G.F. Korytina, T.V. Victorova, 2011, published in Genetika, 2011, Vol. 47, No.10, pp. 1402–1410.
Rights and permissions
About this article
Cite this article
Akhmadishina, L.Z., Korytina, G.F. & Victorova, T.V. CYP1B1 (4326C > G), CYP2F1 (c.14_15insC), CYP2J2 (−76G > T), and CYP2S1 (13106C > T and 13255A > G) polymorphisms and genetic predisposition to chronic respiratory diseases induced by smoking and occupational factors. Russ J Genet 47, 1248–1255 (2011). https://doi.org/10.1134/S102279541109002X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S102279541109002X